Abstracts

Citation

Warren A. Andiman, M.D., Miriam Chernoff, Ph.D., Charles Debeaux Mitchell, M.D., James M. Oleske, M.D., Philimon Gona, Ph.D., Murli Purswani, M.D., Jennifer R. Tappenden, B.A., George Seage, III, Sc.D., M.P.H. Occurrence of renal diseases/laboratory abnormalities among HIV-infected children enrolled in PACTG 219/219C - iDACS 617. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Akihiko Saitoh, M.D., Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Terence Fenton, Ed.D., Carmelita Alvero, Stephen A. Spector, M.D. CYP2B6-G516T polymorphisms influence plasma concentrations of efavirenz in HIV-1 infected children receiving HAART. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Ruth E. Dickover, Ph.D., Diane Claire Smith, B.A., M.T. (A.S.C.P.), Paula Britto, M.S., ChengCheng Hu, Ph.D., Adriana Weinberg, M.D., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D. TREC response in P1021: a once daily regimen of emtricitabine, didanosine and efavirenz in previously naive children. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Adriana Weinberg, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Ruth E. Dickover, Ph.D., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D. Virologic and immunologic correlates of immune reconstitution in HIV-infected children on FTC/DDI/EFV: PACTG protocol P1021. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Deborah Persaud, M.D., Paul Palumbo, M.D., Carrie Ziemniak, Peter Havens, M.D., Ellen Gould Chadwick, M.D. Acquisition and archiving of non-nucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 variants during mother-to-child transmission in U.S. born infants. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Marilyn Jean Crain, M.P.H., M.D., Miriam Chernoff, Ph.D., Jennifer R. Tappenden, B.A., Divna Djokic, M.D., Peggy R. Borum, Ph.D., Kathleen Malee, Ph.D., James M. Oleske, M.D., William A. Meyer, III, Ph.D., Wendy G Mitchell, M.D., Elizabeth (Betsy) Smith, M.D., Russell B. Van Dyke, M.D. Analysis of possible mitochondrial dysfunction in a cohort of children with HIV infection: comparison of the use of two clinical case definitions with a computer algorithm incorporating the medical dictionary for regulatory activities (MedDRA) - iDACS 616. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Elizabeth (Betsy) J. McFarland, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Ram Yogev, M.D., Lisa M. Frenkel, M.D., Terence Fenton, Ed.D., John ( Jack ) Moye, Jr., M.D., Edmund Capparelli, Pharm.D., Paul Harding, M.S., Barbara E. Heckman, B.S. Increasing HIV-specific responses associated with decreasing viral loads after supervised treatment interruption (STI) in children. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Jeffrey Anderson, M.P.H., Myron Levin, M.D., Paige L. Williams, Ph.D., George Seage, III, Sc.D., M.P.H. Incidence and predictors of Herpes Zoster in pediatric HIV in the HAART era - iDACS 615. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Mona Rigaud, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Adriana Weinberg, M.D., Philip LaRussa, M.D., Terence Fenton, Ed.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Patrick Jean-Philippe, M.D., Bonnie Zimmer, B.S., Dorothy Smith, M.S., C.P.N.P. Serological responses to recall and neoantigens in severely immunocompromised HIV-infected children initiating HAART enrolled in PACTG 1006. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Mark Mirochnick, M.D., Alice M. Stek, M.D., Edmund Capparelli, Pharm.D., Brookie M. Best, Pharm.D., Diane Holland, M.Phil., James D. Connor, M.D., ChengCheng Hu, Ph.D., Elizabeth (Betsy) Smith, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H. Adequate lopinavir exposure achieved with a higher dose during the 3rd trimester of pregnancy. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.